Patents by Inventor Dan Alminana

Dan Alminana has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210205342
    Abstract: Provided herein are methods and compositions related to treating and/or preventing liver related diseases and disorders and for improving liver health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: March 16, 2018
    Publication date: July 8, 2021
    Inventors: Ryan Dellinger, Santiago Roel Santos, Eric Marcotulli, Dan Alminana, Mark Morris, Leonard Pershing Guarente
  • Publication number: 20210186996
    Abstract: Provided herein are methods and compositions related to treating and/or preventing multiple sclerosis in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: November 30, 2018
    Publication date: June 24, 2021
    Inventors: Eric Marcotulli, Dan Alminana, Mark Morris, Ryan Dellinger
  • Publication number: 20210177875
    Abstract: Provided herein are methods and compositions related to treating and/or preventing obesity and/or conditions associated with obesity in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: November 30, 2018
    Publication date: June 17, 2021
    Inventors: Eric Marcotulli, Dan Alminana, Mark Morris, Ryan Dellinger
  • Publication number: 20200384004
    Abstract: Provided herein are methods and compositions related to treating and/or preventing glaucoma in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: November 30, 2018
    Publication date: December 10, 2020
    Inventors: Eric Marcotulli, Dan Alminana, Mark Morris, Ryan Dellinger
  • Publication number: 20200330496
    Abstract: Provided herein are methods and compositions related to treating and/or preventing premature aging diseases and/or progeroid syndromes in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: October 5, 2018
    Publication date: October 22, 2020
    Inventors: Eric Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris
  • Publication number: 20200330497
    Abstract: Provided herein are methods and compositions related to treating and/or preventing diseases or disorder associated with cytoplasmic accumulation of TDB-43 by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: October 19, 2018
    Publication date: October 22, 2020
    Inventors: Eric A. Marcotulli, Dan Alminana, Mark Morris, Ryan Dellinger
  • Publication number: 20200140475
    Abstract: Provided herein are efficient and scalable methods for the synthesis of nicotinamide riboside from riboside triacetate. Also provided are compositions comprising nicotinamide riboside, and therapeutic methods employing nicotinamide riboside.
    Type: Application
    Filed: June 29, 2018
    Publication date: May 7, 2020
    Inventors: Eric Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris, Rajesh Thamatam
  • Publication number: 20200085849
    Abstract: Provided herein are methods and compositions related to treating and/or preventing sleep disorders and for improving sleep health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: May 18, 2018
    Publication date: March 19, 2020
    Inventors: Eric A. Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris
  • Publication number: 20190201426
    Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating neurodegenerative disorders, and methods of treating neurodegenerative disorders using these compositions and their equivalents are described. The neurodegenerative disorders that can be treated using these compositions or methods can include parkinson's disease, huntington's disease, alzheimer's disease, and the like. In an embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene can be prepared as oral formulations. In some embodiments, a dietary supplement comprises nicotinamide riboside and/or pterostilbene or equivalents.
    Type: Application
    Filed: August 22, 2017
    Publication date: July 4, 2019
    Inventors: Eric Marcotulli, Dan Alminana
  • Publication number: 20180353497
    Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating skin disorders, and methods of treating skin disorders using these compositions and their equivalents are described. The skin disorders that are treated using these compositions or methods include sun exposure-related skin disorders, inflammatory skin disorders, autoimmune disease-related skin disorders and cancer-related skin disorders. In one embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene are prepared as oral formulations.
    Type: Application
    Filed: February 25, 2016
    Publication date: December 13, 2018
    Inventors: Eric Marcotulli, Dan Alminana
  • Publication number: 20180303861
    Abstract: Provided herein are methods and compositions related to treating and/or preventing kidney related diseases and disorders, treating and/or preventing acute kidney injury, and for improving kidney health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: April 23, 2018
    Publication date: October 25, 2018
    Inventors: Eric Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris